严重精神疾病中的大脑分子年龄偏大
该研究在214名20-90岁对照者两个额叶皮层脑区死后样本中进行大规模基因表达和基因型分析,基于年龄依赖基因估计分子年龄并计算偏离实际年龄的delta age,发现双相障碍和精神分裂症中分子年龄升高,而重性抑郁障碍中无变化,提示分子脑老化偏大是严重精神疾病和神经退行的共同特征。
要点
- 基于年龄依赖基因估计的分子年龄在双相障碍和精神分裂症中升高。
- 重性抑郁障碍中分子年龄未见变化。
- delta age多基因风险评分与精神分裂症、重性抑郁障碍诊断及阿尔茨海默病病理相关。
核心结论
- 分子脑老化偏大是严重精神疾病和神经退行的共同特征。
研究设计与样本
- 在214名20-90岁对照者两个额叶皮层脑区死后样本中进行大规模基因表达和基因型分析。
- 通过稳健回归分析识别年龄依赖基因,据此估计个体分子年龄并计算delta age。
- 利用年龄依赖基因的cis-eQTL或delta age的GWAS构建多基因风险评分,在独立死后表达数据集和临床队列中验证。
主要发现
- 两个脑区分别由68和76个年龄相关基因定义的分子年龄与实际年龄正相关(r=0.88/0.91)。
- 分子年龄在双相障碍和精神分裂症中升高,在重性抑郁障碍中无变化。
- 探索性分析显示多基因风险评分与精神分裂症和重性抑郁障碍诊断相关,并与精神分裂症认知及阿尔茨海默病病理相关。
临床怎么用
- 分子年龄和delta age多基因风险评分可作为严重精神疾病与神经退行风险研究的候选生物标志物。
局限性
- 多基因风险评分与诊断、认知及阿尔茨海默病病理的关联来自探索性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psychiatric disorders are associated with accelerated aging and enhanced risk for neurodegenerative disorders. Brain aging is associated with molecular, cellular, and structural changes that are robust on the group level, yet show substantial inter-individual variability. Here we assessed deviations in gene expression from normal age-dependent trajectories, and tested their validity as predictors of risk for major mental illnesses and neurodegenerative disorders. We performed large-scale gene expression and genotype analyses in postmortem samples of two frontal cortical brain regions from 214 control subjects aged 20-90 years. Individual estimates of "molecular age" were derived from age-dependent genes, identified by robust regression analysis. Deviation from chronological age was defined as "delta age". Genetic variants associated with deviations from normal gene expression patterns were identified by expression quantitative trait loci (cis-eQTL) of age-dependent genes or genome-wide association study (GWAS) on delta age, combined into distinct polygenic risk scores (PRScis-eQTL and PRSGWAS), and tested for predicting brain disorders or pathology in independent postmortem expression datasets and clinical cohorts. In these validation datasets, molecular ages, defined by 68 and 76 age-related genes for two brain regions respectively, were positively correlated with chronological ages (r = 0.88/0.91), elevated in bipolar disorder (BP) and schizophrenia (SCZ), and unchanged in major depressive disorder (MDD). Exploratory analyses in independent clinical datasets show that PRSs were associated with SCZ and MDD diagnostics, and with cognition in SCZ and pathology in Alzheimer's disease (AD). These results suggest that older molecular brain aging is a common feature of severe mental illnesses and neurodegeneration.
引用
- Lin CW, Chang LC, Ma T, et al. Older molecular brain age in severe mental illness. Mol Psychiatry. 2020. PMID: 32632206. doi:10.1038/s41380-020-0834-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。